-
1
Xeroderma pigmentosum. Case presentation.
Published 2008-08-01“…At the age of 6 it was assessed as xeroderma pigmentosum. This diagnosis was confirmed at the age of 10 by the histopathology department and reassessed by the National Reference Centre. …”
Get full text
Article -
2
Xeroderma Pigmentosum: Man Deprived of His Right to Light
Published 2013-01-01“…Xeroderma pigmentosum (XP) is a hereditary autosomal recessive disorder characterized by photo hypersensitivity of sun exposed tissues and subsequent several-fold increased risk for malignant changes resulting from impaired ability to repair UV-induced DNA damage. …”
Get full text
Article -
3
Young Cuban Patients with a Clinical and biochemical Diagnosis of Xeroderma Pigmentosum
Published 2024-08-01“…<strong>Foundation:</strong> skin cancer is a complication of xeroderma pigmentosum; early diagnosis is important. The alkaline comet assay with ultraviolet C radiation and the western blot assay are useful for diagnosis. …”
Get full text
Article -
4
Xeroderma Pigmentosum with Severe Neurological Manifestations/De Sanctis–Cacchione Syndrome and a Novel XPC Mutation
Published 2017-01-01“…Several genetic disorders caused by defective nucleotide excision repair that affect the skin and the nervous system have been described, including Xeroderma Pigmentosum (XP), De Sanctis–Cacchione syndrome (DSC), Cockayne syndrome, and Trichothiodystrophy. …”
Get full text
Article -
5
-
6
-
7
DNA Damage Induced by Alkylating Agents and Repair Pathways
Published 2010-01-01“…., endnuclease xeroderma pigmentosum complementation group F-excision repair cross-complementing rodent repair deficiency complementation group 1), Fanconi anemia repair, and homologous recombination. …”
Get full text
Article -
8
Lung Cancer Risk and Genetic Polymorphisms in DNA Repair Pathways: A Meta-Analysis
Published 2010-01-01“…We conducted a meta-analysis of epidemiologic studies on the association between genetic polymorphisms in both base excision repair and nucleotide excision repair pathways, and lung cancer. We found xeroderma pigmentosum complementation group A (XPA) G23A (odds ratio (OR) =0.76, 95% confidence interval (CI) =0.61–0.94), 8-oxoguanine DNA glycosylase 1 (OGG1) Ser326Cys (OR=1.22, 95% CI=1.02–1.45), and excision repair cross-complementing group 2 (ERCC2) Lys751Gln (OR=1.27, 95% CI=1.10–1.46) polymorphisms were associated with lung cancer risk. …”
Get full text
Article